Minimally invasive glaucoma surgery (MIGS) has established itself in the modern glaucoma management regime to effectively reduce intraocular pressure (IOP).
High frequency deep sclerotomy (HFDS, Oertli Instrumente AG, Switzerland) is a short, implant-free approach to be performed in combination with cataract surgery or as a stand-alone application.
Available on Oertli’s Catarhex3, Faros, and OS4 phaco platforms, the Abee glaucoma tip consists of a coaxial electrode that is used to create six small pockets in the iridocorneal angle for a direct channel between the anterior chamber and Schlemm’s canal, bypassing the resistance of the trabecular meshwork.
Results have demonstrated a mean preoperative IOP of 24.5 ±2.1mmHg. After 48 months, the follow-up average IOP was 15.0 ±1.7mmHg with no serious complications observed.1
Contact: Device Technologies (AUS) 1800 804 006
Reference
1. Pajic, B., et al., High-frequency deep sclerotomy, A minimal invasive ab interno glaucoma procedure combined with cataract surgery: Physical properties and clinical outcome. Appl. Sci. 2020, 10, 218. doi.org/10.3390/app10010218.
